These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 123826)

  • 21. Production of anti-self-h-2 antibodies by C3D2F1 mice hyperimmune to L cell/L1210 hybrids and L1210 leukemia cells.
    Kawashima K; Watanabe E; Isobe K; Ogura M; Nagura E; Yamada K; Sobue I; Mizoguchi K; Ito Y; Nagai Y; Nakashima I
    Cell Immunol; 1982 Mar; 67(2):279-86. PubMed ID: 7083334
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the cytolytic action of guinea pig and rabbit complement on sensitized nucleated mouse cells.
    Koene RA; McKenzie IF
    J Immunol; 1973 Dec; 111(6):1894-901. PubMed ID: 4750871
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor.
    Biddison WE; Palmer JC; Alexander MA; Cowan EP; Manson LA
    J Immunol; 1977 Jun; 118(6):2243-53. PubMed ID: 68083
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated immune response in vitro. I. The development of suppressor cells and cytotoxic lymphocytes in mixed lymphocyte cultures.
    Hirano T; Nordin AA
    J Immunol; 1976 Apr; 116(4):1115-22. PubMed ID: 130426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia.
    Nicolin A; Canti G; Goldin A
    Cancer Res; 1974 Nov; 34(11):3044-8. PubMed ID: 4424774
    [No Abstract]   [Full Text] [Related]  

  • 28. A three-cell model of MLI responsiveness.
    Howe M; Cohen L
    Transplant Proc; 1976 Sep; 8(3):375-9. PubMed ID: 136074
    [No Abstract]   [Full Text] [Related]  

  • 29. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
    Kataoka T; Oh-hashi F
    Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 31. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 32. Mixed lymphocyte reactions: augmentation by drugs that inhibit stimulator cell protein synthesis.
    Metzler CM; Kostyk TG; Gershon RK
    J Immunol; 1976 Oct; 117(4):1295-9. PubMed ID: 135808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR; Fahey KJ
    Adv Exp Med Biol; 1973; 29(0):411-7. PubMed ID: 4211985
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergy among responding lymphoid cells in the one-way mixed lymphocyte reaction. Interaction between two types of thymus-dependent cells.
    Tittor W; Gerbase-Delima M; Walford RL
    J Exp Med; 1974 Jun; 139(6):1488-98. PubMed ID: 4151454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation antigen expression on murine trophoblast detection by induction of specific alloimmunity.
    Pavia CS; Stites DP; Fraser R
    Cell Immunol; 1981 Oct; 64(1):162-76. PubMed ID: 6170456
    [No Abstract]   [Full Text] [Related]  

  • 36. Physical properties of mouse spleen cells involved in the mixed leukocyte reaction and graft-vs-host disease.
    el-Arini MO; Osoba D
    J Immunol; 1973 Jun; 110(6):1476-84. PubMed ID: 4145892
    [No Abstract]   [Full Text] [Related]  

  • 37. [In vitro induction of cell-mediated cytotoxicity].
    Lohmann-Matthes M-L
    Allerg Immunol (Leipz); 1973; 19(2-4):297-302. PubMed ID: 4281631
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes.
    Rich SS; Rich RR
    J Exp Med; 1974 Dec; 140(6):1588-603. PubMed ID: 4279271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous development of humoral and cellular tumor-specific immunity against L1210 mouse leukemia.
    Kawashima K; Isobe K; Nagase F; Yokochi T; Nagura E; Hasegawa Y; Morishita H; Yamada K; Nakashima I
    Leuk Res; 1985; 9(7):935-9. PubMed ID: 4021540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous antilymphoma reaction of preleukaemic AKR mice is a non-T-cell killing.
    Gomard E; Leclerc JC; Levy JP
    Nature; 1974 Aug; 250(5468):671-3. PubMed ID: 4854374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.